NO20024623L - Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform - Google Patents
Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallformInfo
- Publication number
- NO20024623L NO20024623L NO20024623A NO20024623A NO20024623L NO 20024623 L NO20024623 L NO 20024623L NO 20024623 A NO20024623 A NO 20024623A NO 20024623 A NO20024623 A NO 20024623A NO 20024623 L NO20024623 L NO 20024623L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- crystal form
- novel process
- new crystal
- imidazopyridine derivative
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000092565 | 2000-03-30 | ||
| PCT/JP2001/002620 WO2001074821A1 (en) | 2000-03-30 | 2001-03-29 | Novel process for producing fused imidazopyridine derivative and novel crystal form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024623D0 NO20024623D0 (no) | 2002-09-26 |
| NO20024623L true NO20024623L (no) | 2002-11-08 |
Family
ID=18607880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024623A NO20024623L (no) | 2000-03-30 | 2002-09-26 | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7049437B2 (pl) |
| EP (1) | EP1270578A4 (pl) |
| JP (1) | JP3481930B2 (pl) |
| KR (1) | KR20020082898A (pl) |
| CN (1) | CN1203073C (pl) |
| AU (1) | AU2001244613A1 (pl) |
| BR (1) | BR0109643A (pl) |
| CA (1) | CA2403131A1 (pl) |
| CZ (1) | CZ20023276A3 (pl) |
| HK (1) | HK1054387A1 (pl) |
| HU (1) | HUP0300580A3 (pl) |
| IL (1) | IL151877A0 (pl) |
| MX (1) | MXPA02009460A (pl) |
| NO (1) | NO20024623L (pl) |
| PL (1) | PL357672A1 (pl) |
| WO (1) | WO2001074821A1 (pl) |
| ZA (1) | ZA200207295B (pl) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0211169A (pt) * | 2001-07-16 | 2004-08-10 | Shionogi & Co | Processo para preparação de derivados de amidina |
| WO2004078173A1 (ja) * | 2003-02-05 | 2004-09-16 | Shionogi & Co., Ltd. | 溶出性の改善された錠剤 |
| BRPI0413558A (pt) | 2003-08-12 | 2006-10-17 | 3M Innovative Properties Co | compostos contendo imidazo substituìdo por hidroxilamina |
| AU2004268625B2 (en) | 2003-08-27 | 2011-03-31 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| AU2004270201A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
| AR046046A1 (es) | 2003-10-03 | 2005-11-23 | 3M Innovative Properties Co | Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas. |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| CA2545825A1 (en) * | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| EP1685129A4 (en) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
| CA2547020C (en) | 2003-11-25 | 2014-03-25 | 3M Innovative Properties Company | 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier |
| JP2007517035A (ja) | 2003-12-29 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン |
| EP1699788A2 (en) | 2003-12-30 | 2006-09-13 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides |
| WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| CN1960700A (zh) * | 2004-03-30 | 2007-05-09 | 荷兰联合利华有限公司 | 含维生素和类黄酮的亮肤组合物 |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US20070259881A1 (en) * | 2004-06-18 | 2007-11-08 | Dellaria Joseph F Jr | Substituted Imidazo Ring Systems and Methods |
| WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| JP5543068B2 (ja) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| EP1831221B1 (en) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| AU2006213746A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods |
| EP1869043A2 (en) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| AU2006292119A1 (en) * | 2005-09-23 | 2007-03-29 | 3M Innovative Properties Company | Method for 1H-imidazo[4,5-c]pyridines and analogs thereof |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| ES2966512T3 (es) * | 2019-04-12 | 2024-04-22 | Blueprint Medicines Corp | Formas cristalinas de (S)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1H-pirazol-4-il)pirrolo[2,1-f][1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina y métodos de elaboración |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378848A (en) | 1992-02-12 | 1995-01-03 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
-
2001
- 2001-03-29 PL PL01357672A patent/PL357672A1/pl not_active Application Discontinuation
- 2001-03-29 JP JP2001572511A patent/JP3481930B2/ja not_active Expired - Fee Related
- 2001-03-29 HU HU0300580A patent/HUP0300580A3/hu unknown
- 2001-03-29 CZ CZ20023276A patent/CZ20023276A3/cs unknown
- 2001-03-29 CN CNB018073417A patent/CN1203073C/zh not_active Expired - Fee Related
- 2001-03-29 CA CA002403131A patent/CA2403131A1/en not_active Abandoned
- 2001-03-29 HK HK03106654.1A patent/HK1054387A1/zh unknown
- 2001-03-29 US US10/239,785 patent/US7049437B2/en not_active Expired - Fee Related
- 2001-03-29 IL IL15187701A patent/IL151877A0/xx unknown
- 2001-03-29 BR BR0109643-5A patent/BR0109643A/pt not_active IP Right Cessation
- 2001-03-29 WO PCT/JP2001/002620 patent/WO2001074821A1/ja not_active Ceased
- 2001-03-29 AU AU2001244613A patent/AU2001244613A1/en not_active Abandoned
- 2001-03-29 KR KR1020027012412A patent/KR20020082898A/ko not_active Ceased
- 2001-03-29 MX MXPA02009460A patent/MXPA02009460A/es not_active Application Discontinuation
- 2001-03-29 EP EP01917588A patent/EP1270578A4/en not_active Withdrawn
-
2002
- 2002-09-11 ZA ZA200207295A patent/ZA200207295B/en unknown
- 2002-09-26 NO NO20024623A patent/NO20024623L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1270578A1 (en) | 2003-01-02 |
| US7049437B2 (en) | 2006-05-23 |
| BR0109643A (pt) | 2003-04-22 |
| IL151877A0 (en) | 2003-04-10 |
| CN1419557A (zh) | 2003-05-21 |
| MXPA02009460A (es) | 2003-02-12 |
| CZ20023276A3 (cs) | 2003-02-12 |
| HUP0300580A3 (en) | 2006-06-28 |
| HK1054387A1 (zh) | 2003-11-28 |
| CA2403131A1 (en) | 2001-10-11 |
| NO20024623D0 (no) | 2002-09-26 |
| JP3481930B2 (ja) | 2003-12-22 |
| HUP0300580A2 (hu) | 2003-07-28 |
| PL357672A1 (pl) | 2004-07-26 |
| CN1203073C (zh) | 2005-05-25 |
| ZA200207295B (en) | 2003-09-11 |
| US20030088102A1 (en) | 2003-05-08 |
| KR20020082898A (ko) | 2002-10-31 |
| AU2001244613A1 (en) | 2001-10-15 |
| EP1270578A4 (en) | 2004-11-03 |
| WO2001074821A1 (en) | 2001-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024623L (no) | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform | |
| NO20030844D0 (no) | Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| NO20031694D0 (no) | Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament | |
| NO20022176D0 (no) | Absorberende gjenstand og fremgangsmåte for fremstilling av denne | |
| NO20032518L (no) | Fremgangsmåte for fremstilling av amlodipinmaleat | |
| CY2009001I2 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
| NO20013943D0 (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20023950D0 (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| NO20024321D0 (no) | Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin | |
| NO20003555L (no) | Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer | |
| NO20021124D0 (no) | Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor | |
| NO20031413L (no) | Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt | |
| NO20025069L (no) | Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme | |
| NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20023973D0 (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| NO20023577L (no) | Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider | |
| NO20030587L (no) | Fremgangsmåte til fremstilling av diskodermolid og analoger derav | |
| NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20032297L (no) | Fremgangsmåte for fremstilling av distamycinderivater | |
| NO20025385L (no) | Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |